Kv1.1

Potassium channel, voltage gated shaker related subfamily A, member 1
Rendering of KCNA1 from PDB 1dsx
Available structures PDB Ortholog search: PDBe, RCSB List of PDB id codes 2AFL
Identifiers
Symbols	KCNA1 ; AEMK; EA1; HBK1; HUK1; KV1.1; MBK1; MK1; RBK1
External IDs	OMIM: 176260 MGI: 96654 HomoloGene: 183 IUPHAR: 538 ChEMBL: 2309 GeneCards: KCNA1 Gene
Gene ontology Molecular function • voltage-gated potassium channel activity • delayed rectifier potassium channel activity • potassium channel activity • protein binding • potassium ion transmembrane transporter activity Cellular component • endoplasmic reticulum • cytosol • plasma membrane • integral component of plasma membrane • voltage-gated potassium channel complex • cell surface • cytoplasmic membrane-bounded vesicle • apical plasma membrane • cell junction • dendrite • paranode region of axon • presynaptic membrane • neuronal cell body • perikaryon • axon terminus • juxtaparanode region of axon • synapse Biological process • startle response • potassium ion transport • regulation of muscle contraction • synaptic transmission • neuroblast proliferation • cell communication by electrical coupling • magnesium ion homeostasis • neuronal action potential • hippocampus development • neuronal signal transduction • cellular protein localization • regulation of ion transmembrane transport • regulation of membrane potential • neuromuscular process • detection of mechanical stimulus involved in sensory perception of pain • detection of mechanical stimulus involved in sensory perception of touch • protein homooligomerization • cellular response to magnesium ion • potassium ion transmembrane transport Sources: Amigo / QuickGO
Orthologs
Species	Human	Mouse
Entrez	3736	16485
Ensembl	ENSG00000111262	ENSMUSG00000047976
UniProt	Q09470	P16388
RefSeq (mRNA)	NM_000217	NM_010595
RefSeq (protein)	NP_000208	NP_034725
Location (UCSC)	Chr 12: 4.91 – 4.93 Mb	Chr 6: 126.64 – 126.65 Mb
PubMed search	[1]	[2]

Potassium voltage-gated channel subfamily A member 1 also known as K_v1.1 is a shaker related voltage-gated potassium channel that in humans is encoded by the KCNA1 gene. The Isaacs syndrome is a result of an autoimmune reaction against the K_v1.1 ion channel.

Genomics

The gene is located on the Watson (plus) strand of the short arm of chromosome 12 (12p13.32). The gene itself is 8,348 bases in length and encodes a protein of 495 amino acids (predicted molecular weight 56.466 kiloDaltons).

Alternative names

The recommended name for this protein is potassium voltage-gated channel subfamily A member 1 but a number of alternatives have been used in the literature including HuK1 (human K⁺ channel I), RBK1 (rubidium potassium channel 1), MBK (mouse brain K⁺ channel), voltage gated potassium channel HBK1, voltage gated potassium channel subunit K_v1.1, voltage-gated K⁺ channel HuKI and AEMK (associated with myokymia with periodic ataxia).

Structure

The protein is believed to have six domains (S1-S6) with the loop between S5 and S6 forming the channel pore. This region also has a conserved selectivity filter motif. The functional channel is a homotetramer. The N-terminus of the protein associates with β subunits. These subunits regulate channel inactivation as well as its expression. The C-terminus is associated with a PDZ domain protein involved in channel targeting.

Function

The protein functions as a potassium selective channel through which the potassium ion may pass in consensus with the electrochemical gradient. They play a role in repolarisation of membranes.

RNA editing

The pre-mRNA of this protein is subject to RNA editing.

Type

A to I RNA editing is catalyzed by a family of adenosine deaminases acting on RNA (ADARs) that specifically recognize adenosines within double-stranded regions of pre-mRNAs (e.g. Potassium channel RNA editing signal) and deaminate them to inosine. Inosines are recognised as guanosine by the cells translational machinery. There are three members of the ADAR family ADARs 1-3 with ADAR1 and ADAR2 being the only enzymatically active members. ADAR3 is thought to have a regulatory role in the brain. ADAR1 and ADAR2 are widely expressed in tissues while ADAR3 is restricted to the brain. The double stranded regions of RNA are formed by base-pairing between residues in the region close to the editing site with residues usually in a neighboring intron but can sometimes be an exonic sequence too. The region that base pairs with the editing region is known as an Editing Complementary Sequence (ECS).

Location

The modified residue is found at amino acid 400 of the final protein. This is located in the sixth transmembrane region found, which corresponds to the inner vestibule of the pore. A stem loop hairpin structure mediates the RNA editing. ADAR2 is likely to be the preferred editing enzyme at the I/V site. Editing results in a codon alteration from ATT to GTT, resulting in an amino acid change from isoleucine to valine. ADAR2 enzyme is the major editing enzyme. The MFOLD programme predicted that the minimum region required for editing would form an imperfect inverted repeat hairpin. This region is composed of a 114 base pairs. Similar regions have been identified in mouse and rat. The edited adenosine is found in a 6-base pair duplex region. Mutation experiment in the region near the 6-base pair duplex have shown that the specific bases in this region were also essential for editing to occur. The region required for editing is unusual in that the hairpin structure is formed by exonic sequences only. In the majority of A to I editing the ECS is found within an intronic sequence.

Conservation

The editing is highly conserved having been observed in squid, fruit fly, mouse, and rat.

Regulation

Editing levels vary in different tissues: 17% in the caudate nucleus, 68% in the spinal cord, and 77% in the medulla.

Consequences

Structure

Editing results in a codon (I/V) change from (ATT) to (GTT) resulting in translation of a valine instead of an isoleucine at the position of the editing site. Valine has a larger side-chain. RNA editing at this position occurs at a highly conserved ion conducting pore of the channel. This may affect the channels role in the process of fast inactivation.

Function

Voltage-dependent potassium channels modulate excitability by opening and closing a potassium selective pore in response to voltage. The flow of potassium ions is interrupted by interaction of an inactivating particle, an auxiliary protein in humans but an intrinsic part of the channel in other species. The I to V amino acid change is thought to disrupt the hydrophobic interaction between the inactivating particle and the pore lining. This interrupts the process of fast inactivation. Activation kinetics are unaffected by RNA editing. Changes in inactivation kinetics have an impact on the duration and frequency of the action potential. An edited channel passes more current and has a shorter action potential than the non-edited type due to the inability of the inactivating particle to interact with the residue in the ion-conducting pore of the channel.This was determined by electrophysiology analysis. The length of time the membrane is depolarised is decreased, which also reduces the efficiency of transmitter release. Since editing can cause amino acid changes in 1- 4 in potassium channel tetramers, it can have a wide variety of effects on channel inactivation.

Dysregulation

Changes in the process of fast inactivation are known to have behavioral and neurological consequences in vivo.

Clinical

Mutations in this gene cause episodic ataxia type 1.

See also

• GABRA3 - a channel subunit which undergoes similar RNA editing

External links

• GeneReviews/NCBI/NIH/UW entry on Episodic Ataxia Type 1,Episodic Ataxia with Myokymia, Hereditary Cerebellar Ataxia with Neuromyotonia
• Kv1.1 Potassium Channel at the US National Library of Medicine Medical Subject Headings (MeSH)
• KCNA1 protein, human at the US National Library of Medicine Medical Subject Headings (MeSH)